DEFB132: A Potential Drug Target Or Biomarker (G400830)

Target Name: DEFB132

NCBI ID: G400830

DEFB132: A Potential Drug Target Or Biomarker

Beta-defensin 132 (DEFB132) is a protein that is expressed in various tissues of the body, including the skin, hair, and nails. It plays a crucial role in the immune system, helping to defend against pathogens and other harmful substances that may enter the body.

Recent studies have suggested that DEFB132 may have potential as a drug target or biomarker. In this article, we will explore the biology and potential applications of DEFB132.

The Biology of DEFB132

DEFB132 is a 21-kDa protein that is expressed in various tissues of the body. It is highly conserved, with only a minor difference in its amino acid sequence between the mouse and human species. DEFB132 is involved in the immune response, specifically in the regulation of inflammation and infection.

One of the key functions of DEFB132 is its role in the regulation of T cell responses. T cells are a crucial part of the immune system, responsible for recognizing and responding to foreign substances in the body. DEFB132 has been shown to regulate the activity of T cells, allowing them to either help fight off infections or stand by and allow other immune cells to take over.

In addition to its role in T cell regulation, DEFB132 is also involved in the regulation of inflammation. When the body is exposed to an pathogen or other harmful substance, DEFB132 helps to coordinate the immune response and clear the pathogen from the body.

Potential Applications of DEFB132

The potential applications of DEFB132 are vast, and several studies have suggested that it may be a valuable drug target or biomarker. One of the most promising applications of DEFB132 is its potential as a therapeutic agent for skin diseases, such as psoriasis and dermatitis.

Several studies have shown that DEFB132 can help to reduce inflammation and improve the symptoms of skin diseases. In addition, DEFB132 has also been shown to help regulate the immune response, which may be useful in treating autoimmune diseases such as rheumatoid arthritis.

Another potential application of DEFB132 is its use as a biomarker for cancer. Several studies have shown that DEFB132 can be expressed in a variety of cancer types, including breast, ovarian, and prostate cancer. This suggests that DEFB132 may be a useful biomarker for these cancers, allowing for the early detection and treatment of these diseases.

In addition to its potential as a drug or biomarker, DEFB132 has also been shown to have potential as an adjunctive therapy for certain cancers. In one study, DEFB132 was found to improve the efficacy of chemotherapy in treating breast cancer.

Conclusion

In conclusion, DEFB132 is a protein that is involved in the immune system and has been shown to play a crucial role in the regulation of inflammation and infection. Its potential applications as a drug target or biomarker are vast and varied, including the treatment of skin diseases, autoimmune diseases, and cancer. Further research is needed to fully understand the biology and potential applications of DEFB132.

Protein Name: Defensin Beta 132

Functions: Has antibacterial activity

More Common Targets